Molecular Interplay between hypertension and dyslipidemia in cardiovascular pathogenesis: toward precision-based therapeutic strategies - Top-Institutions - MDSpire

Molecular Interplay between hypertension and dyslipidemia in cardiovascular pathogenesis: toward precision-based therapeutic strategies

  • By

  • Boming Cao

  • Jingyi Pei

  • Ling Kong

  • Ying Han

  • Guangli Yan

  • Xijun Wang

  • June 11, 2026

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, Ohio

    Key Differentiators

    • Cardiology
    • Hypertension
    • Lipid Disorders

  • #2

    Brigham and Women’s Hospital
    Brigham and Women’s Hospital

    Boston, Massachusetts

    Key Differentiators

    • Cardiology
    • Hypertension
    • Vascular Medicine

Original Source(s)

Molecular Interplay between hypertension and dyslipidemia in cardiovascular pathogenesis: toward precision-based therapeutic strategies

  • by Boming Cao, Jingyi Pei, Ling Kong, Ying Han, Guangli Yan, Xijun Wang

  • June 11, 2026

Related Content

Top 10 States With Rising Demand for Physicians

These 10 states report physician shortages, projected physician supply gaps, or physician-to-population ratios below national benchmarks.

Co-culture with fibroblasts in stiff 3D scaffolds increases CD54 and CD140a expression on macrophages

AD Not Linked to Early CV Risk Markers

Repeated assessments from childhood to early adulthood did not identify consistent cardiometabolic risk patterns by disease activity or severity.